|
1
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma-an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang SK, Zheng R, Chen Q, Zhang S, Sun X
and Chen W: Oral cancer incidence and mortality in China, 2011.
Chin J Cancer Res. 27:44–51. 2015.PubMed/NCBI
|
|
3
|
Brands MT, Brennan PA, Verbeek ALM, Merkx
MAW and Geurts SME: Follow-up after curative treatment for oral
squamous cell carcinoma. A critical appraisal of the guidelines and
a review of the literature. Eur J Surg Oncol. 44:559–565. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morra F, Merolla F, Picardi I, Russo D,
Ilardi G, Varricchio S, Liotti F, Pacelli R, Palazzo L, Mascolo M,
et al: CAF-1 subunits levels suggest combined treatments with
PARP-inhibitors and ionizing radiation in advanced HNSCC. Cancers
(Basel). 11:15822019. View Article : Google Scholar
|
|
5
|
Sasahira T and Kirita T: Hallmarks of
cancer-related newly prognostic factors of oral squamous cell
carcinoma. Int J Mol Sci. 19:24132018. View Article : Google Scholar
|
|
6
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng Z, Zhang C and Duan C: Functions and
mechanisms of long noncoding RNAs in lung cancer. Onco Targets
Ther. 9:4411–4424. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin Z, Jiang S, Jian S and Shang Z: Long
noncoding RNA MORT overexpression inhibits cancer cell
proliferation in oral squamous cell carcinoma by downregulating
ROCK1. J Cell Biochem. Feb 25–2019.(Epub ahead of print). doi:
10.1002/jcb.28449. View Article : Google Scholar
|
|
9
|
Yang Y, Chen D, Liu H and Yang K:
Increased expression of lncRNA CASC9 promotes tumor progression by
suppressing autophagy-mediated cell apoptosis via the AKT/mTOR
pathway in oral squamous cell carcinoma. Cell Death Dis. 10:412019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao L, Guo H, Zhou B, Feng J, Li Y, Han
T, Liu L, Li L, Zhang S, Liu Y, et al: Long non-coding RNA SNHG5
suppresses gastric cancer progression by trapping MTA2 in the
cytosol. Oncogene. 35:5770–5780. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu X, Hong Y and Shang C: Knockdown of
long non-coding RNA SNHG5 inhibits malignant cellular phenotypes of
glioma via Wnt/CTNNB1 signaling pathway. J Cancer. 10:1333–1340.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang M, Li Q, Pan Y, Wang H, Liu G and
Yin H: MicroRNA-655 attenuates the malignant biological behaviours
of retinoblastoma cells by directly targeting PAX6 and suppressing
the ERK and p38 MAPK signalling pathways. Oncol Rep. 39:2040–2050.
2018.PubMed/NCBI
|
|
13
|
Kiuchi J, Komatsu S, Imamura T, Nishibeppu
K, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Okamoto K, et
al: Low levels of tumour suppressor miR-655 in plasma contribute to
lymphatic progression and poor outcomes in oesophageal squamous
cell carcinoma. Mol Cancer. 18:22019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gajera M, Desai N, Suzuki A, Li A, Zhang
M, Jun G, Jia P, Zhao Z and Iwata J: MicroRNA-655-3p and
microRNA-497-5p inhibit cell proliferation in cultured human lip
cells through the regulation of genes related to human cleft lip.
BMC Med Genomics. 12:702019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Cao R, Su W, Li Y and Yan H:
miR-655-3p inhibits cell migration and invasion by targeting
pituitary tumor-transforming 1 in non-small cell lung cancer.
Biosci Biotechnol Biochem. 83:1703–1708. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin J, Zandi R, Shao R, Gu J, Ye Y, Wang
J, Zhao Y, Pertsemlidis A, Wistuba II, Wu X, et al: A miR-SNP
biomarker linked to an increased lung cancer survival by
miRNA-mediated down-regulation of FZD4 expression and Wnt
signaling. Sci Rep. 7:90292017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gupta S, Iljin K, Sara H, Mpindi JP,
Mirtti T, Vainio P, Rantala J, Alanen K, Nees M and Kallioniemi O:
FZD4 as a mediator of ERG oncogene-induced WNT signaling and
epithelial-to-mesenchymal transition in human prostate cancer
cells. Cancer Res. 70:6735–6745. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen L, Long Y, Han Z, Yuan Z, Liu W, Yang
F, Li T, Shu L and Zhong Y: MicroRNA-101 inhibits cell migration
and invasion in bladder cancer via targeting FZD4. Exp Ther Med.
17:1476–1485. 2019.PubMed/NCBI
|
|
19
|
Wang Y, Zhang W, Wang Y and Wang S:
HOXD-AS1 promotes cell proliferation, migration and invasion
through miR-608/FZD4 axis in ovarian cancer. Am J Cancer Res.
8:170–182. 2018.PubMed/NCBI
|
|
20
|
Tan J, Xiang L and Xu G: lncRNA MEG3
suppresses migration and promotes apoptosis by sponging miR-548d-3p
to modulate JAK-STAT pathway in oral squamous cell carcinoma. IUBMB
Life. 71:882–890. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li B, Wang W, Miao S, Li G, Lv Y, Xiang C
and Pei R: HOXA11-AS promotes the progression of oral squamous cell
carcinoma by targeting the miR-518a-3p/PDK1 axis. Cancer Cell Int.
19:1402019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chi JR, Yu ZH, Liu BW, Zhang D, Ge J, Yu Y
and Cao XC: SNHG5 promotes breast cancer proliferation by sponging
the miR-154-5p/PCNA axis. Mol Ther Nucleic Acids. 17:138–149. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Liu L, Luo Y, Cui S, Chen W, Zeng A,
Shi Y and Luo L: Long non-coding RNA SNHG5 promotes glioma
progression via miR-205/E2F3 axis. Biosci Rep. 39:BSR201906682019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Damas ND, Marcatti M, Come C, Christensen
LL, Nielsen MM, Baumgartner R, Gylling HM, Maglieri G, Rundsten CF,
Seemann SE, et al: SNHG5 promotes colorectal cancer cell survival
by counteracting STAU1-mediated mRNA destabilization. Nat Commun.
7:138752016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Guo D, Zhao Y, Ren M, Lu G, Wang Y,
Zhang J, Mi C, He S and Lu X: Long non-coding RNA SNHG5 promotes
human hepatocellular carcinoma progression by regulating
miR-26a-5p/GSK3β signal pathway. Cell Death Dis. 9:8882018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ju C, Zhou R, Sun J, Zhang F, Tang X, Chen
KK, Zhao J, Lan X, Lin S, Zhang Z and Lv XB: lncRNA SNHG5 promotes
the progression of osteosarcoma by sponging the miR-212-3p/SGK3
axis. Cancer Cell Int. 18:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao J, Zeng K, Liu Y, Gao L and Liu L:
lncRNA SNHG5 promotes growth and invasion in melanoma by regulating
the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. 12:169–179. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lv ZD, Kong B, Liu XP, Jin LY, Dong Q, Li
FN and Wang HB: miR-655 suppresses epithelial-to-mesenchymal
transition by targeting Prrx1 in triple-negative breast cancer. J
Cell Mol Med. 20:864–873. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zha JF and Chen DX: miR-655-3p inhibited
proliferation and migration of ovarian cancer cells by targeting
RAB1A. Eur Rev Med Pharmacol Sci. 23:3627–3634. 2019.PubMed/NCBI
|
|
30
|
Wang Y, Zang W, Du Y, Ma Y, Li M, Li P,
Chen X, Wang T, Dong Z and Zhao G: Mir-655 up-regulation suppresses
cell invasion by targeting pituitary tumor-transforming gene-1 in
esophageal squamous cell carcinoma. J Transl Med. 11:3012013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin
X and Cheng Y: MicroRNA-655-3p functions as a tumor suppressor by
regulating ADAM10 and β-catenin pathway in hepatocellular
carcinoma. J Exp Clin Cancer Res. 35:892016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Harazono Y, Muramatsu T, Endo H, Uzawa N,
Kawano T, Harada K, Inazawa J and Kozaki K: miR-655 is an
EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One.
8:e627572013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W,
Su B and Gao W: Downregulation of miR-3127-5p promotes
epithelial-mesenchymal transition via FZD4 regulation of
Wnt/β-catenin signaling in non-small-cell lung cancer. Mol
Carcinog. 57:842–853. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma C, Xu B, Husaiyin S, Wang L,
Wusainahong K, Ma J, Zhu K and Niyazi M: MicroRNA-505 predicts
prognosis and acts as tumor inhibitor in cervical carcinoma with
inverse association with FZD4. Biomed Pharmacother. 92:586–594.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang J, Ye Z, Mei D, Gu H and Zhang J:
Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating
miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
Cancer Manag Res. 11:4209–4221. 2019. View Article : Google Scholar : PubMed/NCBI
|
